ArticleCureus2026
Clinical Low Vision Rehabilitation Interventions in Age-Related Macular Degeneration: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 70-year-old female with bilateral age-related macular degeneration (AMD) - wet AMD in the right eye and dry AMD in the left eye - presented with reduced unaided distance visual acuity of 20/200 (6/60) and near visual acuity of 3.2M (20/160, 6/48) OU. Retinoscopy and subjective refraction showed a prescription of -2.25 -2.50 × 175 in the right eye and +0.50 -1.50 × 120 in the left eye, achieving corrected visual acuities of 20/125 (6/37.5) OU. With an additional +3.00 diopters sphere for near tasks, the patient was able to read up to 2.5M (20/125, 6/37.5), indicating a coexisting refractive error. Amsler grid testing revealed central metamorphopsia and scotomas OU. Optical coherence tomography (OCT) confirmed bilateral drusen, retinal pigment epithelium (RPE) atrophy, and vitreomacular adhesion (VMA), with findings consistent with AMD. Functional contrast sensitivity was reduced (20/100, 6/30) OU, and visual field testing showed central scotomas and metamorphopsia. Low vision rehabilitation included the prescription of a 2.5× binocular Galilean telescope (Eschenbach 1639; Eschenbach Optik GmbH, Nuremberg, Germany) for distance, achieving 20/40 (6/12) vision OU, and a 5× illuminated hand magnifier (Eschenbach Mobilux 15105; Eschenbach Optik GmbH) for near tasks, enabling reading of 1.0M print (approximately 20/50, equivalent to 6/18+). Environmental modifications and contrast-enhancing filters were recommended. Nutritional counseling and ongoing monitoring were initiated, and the patient was educated on self-assessment with the Amsler grid. At three-month follow-up, visual function remained stable, and low vision strategies continued to support functional independence. This case underscores the importance of early low vision intervention, multidisciplinary care, and personalized rehabilitation strategies in maintaining quality of life in patients with AMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.